Over the past 20+ years, Terry Cochrane established himself as a biopharmaceutical CMC specialist. Holding key roles in major operational departments including Quality Assurance, Quality Control, Validation, Manufacturing  Operations, Process Development, Project Management and Business Development, Terry contributed to the CMC portfolios of five commercial and more than thirty biopharmaceutical clinical trial programs. Throughout his career, Terry has developed a vision for simplification and acceleration of the Biopharmaceutical outsourcing process that led him to create BrevisRefero, an intuitive and powerful technology platform leveraging his expertise for the benefit of innovator biotechnology companies, CDMOs, and ultimately patients.  Before becoming president of BrevisRefero, Terry was co-founder & managing director of the Bio-Processing Alliance, where he was responsible for advising clients on their technical programs, developing and running their Request For Proposals, and driving CMC programs to completion. His previous roles included Director Project Operations at QSV Biologics and Analytical Validation Supervisor at Cangene Corporation.